Product Program year 2025 Source: CMS Open Payments

Farapulse

Device Farapulse_Rm

Open in the dashboard

General payments

$1,418,126

2,117 payments

Research payments

$410,000

2 payments

Through program year 2025, $1,418,126 in general payments and $410,000 in research payments were reported against Farapulse (Farapulse_Rm).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

3 rows
Year Kind Amount Payments
2025 General $1,388,334 2,100
2025 Research $410,000 2
2022 General $29,791 17

Breakdown

Who paid General payments · program years 2022–2025
  1. Boston Scientific Corporation $1,418,126 2,117 payments
Top recipients General payments · program year 2025
  1. Walid Saliba Clinical Cardiac Electrophysiology · Cleveland, OH $95,488 7% · 51 payments
  2. Muhie Dean Sabayon Clinical Cardiac Electrophysiology · Galveston, TX $57,901 4% · 21 payments
  3. Jacob Koruth Clinical Cardiac Electrophysiology · New York, NY $48,728 4% · 23 payments
  4. Andrea Natale Clinical Cardiac Electrophysiology · Austin, TX $48,725 4% · 13 payments
  5. Luigi Di Biase Cardiovascular Disease · Bronx, NY $45,820 3% · 19 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Clinical Cardiac Electrophysiology Internal Medicine $1,079,604 79% · 295 practitioners
  2. Cardiovascular Disease Internal Medicine $232,026 17% · 75 practitioners
  3. Internal Medicine $13,666 1% · 20 practitioners
  4. Nurse Practitioner, Family Nurse Practitioner $7,860 <1% · 10 practitioners
  5. Nurse Practitioner, Acute Care Nurse Practitioner $6,012 <1% · 6 practitioners

The top 5 of 27 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. Texas $218,619 16% · 49 recipients
  2. Ohio $181,904 13% · 18 recipients
  3. California $145,952 11% · 47 recipients
  4. New York $144,196 10% · 26 recipients
  5. Florida $81,486 6% · 58 recipients

The top 5 of 41 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

2,117 general · 2 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record